Does lumbar spinal decompression or fusion surgery influence outcome parameters in patients with intrathecal morphine treatment for persistent spinal pain syndrome type 2 (PSPS-T2).

IF 1.5 Q4 CLINICAL NEUROLOGY
Scandinavian Journal of Pain Pub Date : 2023-09-06 Print Date: 2023-10-26 DOI:10.1515/sjpain-2023-0042
Frank Patrick Schwarm, Raza Rehman, Jasmin Nagl, Hanna Gött, Eberhard Uhl, Malgorzata Anna Kolodziej
{"title":"Does lumbar spinal decompression or fusion surgery influence outcome parameters in patients with intrathecal morphine treatment for persistent spinal pain syndrome type 2 (PSPS-T2).","authors":"Frank Patrick Schwarm, Raza Rehman, Jasmin Nagl, Hanna Gött, Eberhard Uhl, Malgorzata Anna Kolodziej","doi":"10.1515/sjpain-2023-0042","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Intrathecal morphine pump (ITMP) infusion therapy is efficient in managing chronic pain refractory to standard treatment. This study evaluates pain relief and improvement of quality of life in chronic pain patients after intrathecal morphine pump implantation for treatment of persistent pain after lumbar spinal fusion surgery and lumbar spinal decompression alone.</p><p><strong>Methods: </strong>Forty three chronic pain patients that received an ITMP at our department between 2009 and 2019 were retrospectively analyzed divided into 2 cohorts (lumbar spinal fusion surgery and lumbar spinal decompression alone). Pain intensity was evaluated using the numeric rating scale (NRS), quality of life was assessed by EQ-5D-3L, mental health was assessed by Beck Depression Inventory (BDI-V), and Pain Catastrophizing Scale (PCS). Morphine dosage was assessed over time. Data was collected preoperatively, 6 and 24 months postoperatively. Statistical analysis was performed using Friedman's analysis of variance to evaluate the development of NRS, PCS, BDI and EQ-5D-3L over time and Mann-Whitney-U-test for the differences between these parameters in the different cohorts. A two-sided p-value <0.05 was considered statistically significant.</p><p><strong>Results: </strong>Median age was 64 years (IQR<sup>25-75</sup> 56-71 years). NRS, EQ-5D-3L, BDI-V, and PCS showed a significant overall improvement after 6 and 24 months compared to baseline data (p<0.001). No statistically significant differences between patients with lumbar spinal fusion surgery and lumbar spinal decompression alone were seen. Furthermore, no statistically significant differences for age and gender were seen. The initially administered median morphine dosage was significantly higher in the fusion group (3.0 mg/day; IQR<sup>25-75</sup> 1.5-4.2 mg/day) compared to the decompression-alone group (1.5 mg/day; IQR<sup>25-75</sup> 1.0-2.6 mg/day); (p=0.027).</p><p><strong>Conclusions: </strong>This retrospective study showed that ITMP have a major long-term impact on pain relief, improve the quality of life, psychological distress, as well as pain catastrophizing in patients with chronic pain following lumbar spinal surgery independent of the previous surgical procedure. After ITMP implantation initial median morphine dosage seems to be significantly higher after spinal fusion compared to decompressive surgery alone.</p>","PeriodicalId":47407,"journal":{"name":"Scandinavian Journal of Pain","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2023-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scandinavian Journal of Pain","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1515/sjpain-2023-0042","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/10/26 0:00:00","PubModel":"Print","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Intrathecal morphine pump (ITMP) infusion therapy is efficient in managing chronic pain refractory to standard treatment. This study evaluates pain relief and improvement of quality of life in chronic pain patients after intrathecal morphine pump implantation for treatment of persistent pain after lumbar spinal fusion surgery and lumbar spinal decompression alone.

Methods: Forty three chronic pain patients that received an ITMP at our department between 2009 and 2019 were retrospectively analyzed divided into 2 cohorts (lumbar spinal fusion surgery and lumbar spinal decompression alone). Pain intensity was evaluated using the numeric rating scale (NRS), quality of life was assessed by EQ-5D-3L, mental health was assessed by Beck Depression Inventory (BDI-V), and Pain Catastrophizing Scale (PCS). Morphine dosage was assessed over time. Data was collected preoperatively, 6 and 24 months postoperatively. Statistical analysis was performed using Friedman's analysis of variance to evaluate the development of NRS, PCS, BDI and EQ-5D-3L over time and Mann-Whitney-U-test for the differences between these parameters in the different cohorts. A two-sided p-value <0.05 was considered statistically significant.

Results: Median age was 64 years (IQR25-75 56-71 years). NRS, EQ-5D-3L, BDI-V, and PCS showed a significant overall improvement after 6 and 24 months compared to baseline data (p<0.001). No statistically significant differences between patients with lumbar spinal fusion surgery and lumbar spinal decompression alone were seen. Furthermore, no statistically significant differences for age and gender were seen. The initially administered median morphine dosage was significantly higher in the fusion group (3.0 mg/day; IQR25-75 1.5-4.2 mg/day) compared to the decompression-alone group (1.5 mg/day; IQR25-75 1.0-2.6 mg/day); (p=0.027).

Conclusions: This retrospective study showed that ITMP have a major long-term impact on pain relief, improve the quality of life, psychological distress, as well as pain catastrophizing in patients with chronic pain following lumbar spinal surgery independent of the previous surgical procedure. After ITMP implantation initial median morphine dosage seems to be significantly higher after spinal fusion compared to decompressive surgery alone.

腰椎减压或融合术是否会影响鞘内吗啡治疗2型持续性脊髓疼痛综合征(PSPS-T2)患者的疗效参数。
目的:鞘内吗啡泵(ITMP)输注治疗是治疗标准治疗难治性慢性疼痛的有效方法。本研究评估了鞘内吗啡泵植入治疗腰椎融合术和单纯腰椎减压后持续疼痛的慢性疼痛患者的疼痛缓解和生活质量的改善。方法:对2009年至2019年间在我科接受ITMP治疗的43名慢性疼痛患者进行回顾性分析,分为2组(腰椎融合术和单纯腰椎减压)。使用数字评定量表(NRS)评估疼痛强度,使用EQ-5D-3L评估生活质量,使用Beck抑郁量表(BDI-V)和疼痛灾难量表(PCS)评估心理健康。吗啡的剂量是随着时间的推移而评估的。术前、术后6个月和24个月收集数据。使用Friedman方差分析进行统计分析,以评估NRS、PCS、BDI和EQ-5D-3L随时间的发展,并对不同队列中这些参数之间的差异进行Mann-Whiteney-U-test。双侧p值结果:中位年龄为64岁(IQR25-75 56-71岁)。与基线数据相比,NRS、EQ-5D-3L、BDI-V和PCS在6个月和24个月后显示出显著的总体改善(p25-75 1.5-4.2 mg/天)与单独减压组(1.5 mg/天;IQR25-75 1.0-2.6 mg/天);(p=0.027)。结论:这项回顾性研究表明,ITMP对腰椎手术后的慢性疼痛患者的疼痛缓解、生活质量改善、心理困扰以及疼痛灾难性发作具有重大的长期影响,与之前的手术无关。ITMP植入后,与单独减压手术相比,脊柱融合后的初始吗啡中位剂量似乎显著更高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Scandinavian Journal of Pain
Scandinavian Journal of Pain CLINICAL NEUROLOGY-
CiteScore
3.30
自引率
6.20%
发文量
73
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信